Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL THIN FILM DRUGS INDUSTRY
2.1 Summary about Thin Film Drugs Industry
2.2 Thin Film Drugs Market Trends
2.2.1 Thin Film Drugs Production & Consumption Trends
2.2.2 Thin Film Drugs Demand Structure Trends
2.3 Thin Film Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Transdermal Film
4.2.2 Oral Thin Film
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Drugstores
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Transdermal Film
5.2.2 Oral Thin Film
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Drugstores
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Transdermal Film
6.2.2 Oral Thin Film
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Drugstores
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Transdermal Film
7.2.2 Oral Thin Film
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Drugstores
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Transdermal Film
8.2.2 Oral Thin Film
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Drugstores
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Transdermal Film
9.2.2 Oral Thin Film
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Drugstores
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 LTS
10.1.2 GSK
10.1.3 J&J
10.1.4 Indivior
10.1.5 Pfizer
10.1.6 Sanofi
10.1.7 Church & Dwight
10.1.8 tesa Labtec
10.1.9 Tapemark
10.1.10 Prestige Bands
10.1.11 Sun Pharma
10.1.12 MonoSol
10.1.13 BioDelivery
10.1.14 Arx
10.1.15 ZIM
10.1.16 NAL Pharma
10.1.17 AdhexPharma
10.1.18 Aavishkar
10.1.19 IntelGenx Corp
10.1.20 APR
10.2 Thin Film Drugs Sales Date of Major Players (2017-2020e)
10.2.1 LTS
10.2.2 GSK
10.2.3 J&J
10.2.4 Indivior
10.2.5 Pfizer
10.2.6 Sanofi
10.2.7 Church & Dwight
10.2.8 tesa Labtec
10.2.9 Tapemark
10.2.10 Prestige Bands
10.2.11 Sun Pharma
10.2.12 MonoSol
10.2.13 BioDelivery
10.2.14 Arx
10.2.15 ZIM
10.2.16 NAL Pharma
10.2.17 AdhexPharma
10.2.18 Aavishkar
10.2.19 IntelGenx Corp
10.2.20 APR
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
